Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex, A Multi-center Randomized Control Trial
Project Description:
This study is a multi-center, prospective, randomized, double-blind, placebo controlled evaluation of the efficacy and safety of a topically applied formulation of rapamycin to cutaneous angiofibromas in subjects with TSC. The primary goal of this study is to evaluate the efficacy of the topical product in patients with TSC. The secondary goal of this study is to evaluate the safety of the topical product for treatment of angiofribromatous cutaneous lesions.
Keyword(s):
tuberous sclerosis, laser therapy, nasolabial fold, facial angiofibroma
Core Function(s):
Performing Direct and/or Demonstration Services, Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Professionals and Para-Professionals, Family Members/Caregivers, Legislators/Policy Makers, General Public
Unserved or Under-served Populations:
None
Primary Target Audience Geographic Descriptor:
Mulit-County
COVID-19 Related Data:
N/A